Press Releases

Page Category: 

Conference Call Accessible Via Live Webcast BOTHELL, WA, February 3, 2005 €“ Sonosite, Inc. (Nasdaq: SONO) today announced that the Company will report its fourth quarter and 2004 year-end financial results on Tuesday, February 15, 2005 after the market close. Sonosite's management team will host a conference call on Tuesday, February 15, 2005 at 1:30 pm (PST)/4:30 pm (EST) to discuss the Company's fourth quarter and year-end results. The call will be broadcast live and can be accessed via the "Investors" Section of Sonosite's website at www.sonosite.com .A replay of the audio webcast will be available beginning February 15, 2005, 4:30 pm (PST) until February 28, 2005, 12:00 midnight (PST) by dialing (719) 457 0820 or toll-free (888) 203 1112. The confirmation code 5110974 is required to access the replay. The call will be also archived on Sonosite's website at http://ir.sonosite.com/. About Sonosite

BOTHELL, WASH., January 21, 2005 €“ Sonosite, Inc. (Nasdaq: SONO), the leader in high performance, hand-carried ultrasound, today announced that it will present at the Piper Jaffray Health Care Conference at The Pierre in New York on Wednesday, January 26, 2005 at 10:00 am (EST). The presentation will include a review of the company's business strategy and historical financial results.A live audio-only webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast will find a link to the webcast registration page on Sonosite's website at http://www.sonosite.com/ . An archived replay of the presentation will also be available approximately one hour following the live presentation and will be available for 30 days. About Sonosite

BOTHELL, WASH., January 6, 2005 €“ Sonosite, Inc. (Nasdaq: SONO) , the leader in high performance, hand-carried ultrasound, today announced that it will present at the 23rd JPMorgan Healthcare Conference at the Westin St Francis in San Francisco on Thursday, January 13, 2005 at 1:30 pm (PST). The presentation will include a review of the company's business strategy and historical financial results.A live audio-only webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast will find a link to the webcast registration page on Sonosite's website at http://www.sonosite.com/ . An archived replay of the presentation will also be available approximately one hour following the live presentation and will be available for 30 days. About Sonosite

Ultrasound-Based Software Allows Physicians to Measure Thickened Arterial WallsBOTHELL, WASH., December 29, 2004 €“ Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, said today that it has begun customer shipments of the SonoCalc IMT„¢ software, which allows physicians to quickly and effectively measure the wall thickness (IMT) of the common carotid arteries and assess a patient's risk of cardiovascular disease. Used in conjunction with the TITAN system - Sonosite's high-resolution, hand-carried ultrasound technology - the SonoCalc„¢ IMT software enables physicians to identify disease at an early stage and to manage it more effectively. The software, which is PC-based, works with digital images downloaded from the TITAN system.

"The start of customer shipments of SonoCalc„¢ IMT signals the beginning of our move into what we believe is an emerging and potentially large preventive cardiology market," said Kevin M. Goodwin, president and CEO of Sonosite, Inc. "This technology offers physicians a low-cost and non-invasive means to identify cardiovascular disease early when it is both treatable and reversible.

New Capabilities Added for Interventional Procedures and General ImagingWorldwide TITAN Installed Base Over 2,500 CHICAGO, November 28, 2004 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, announced today at the 90th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) that it is expanding the clinical capabilities of its high-performance TITAN system in interventional radiology, as well as offering enhanced features which provide important added clinical utility for general imaging applications. The new software upgrade is available immediately.

"This introduction marks the fourth major expansion of the TITAN system platform since initial product launch just 18 months ago," said Kevin M. Goodwin, Sonosite president and CEO. "Our systems are built for portability and upgradeability which is why we are able to offer our customers a continuing stream of performance and feature enhancements on a regular basis. The worldwide installed base of TITAN...

Sonosite Introduces Technology for Early Risk Assessment of Cardiovascular DiseaseSoftware Detects Thickened Arterial Walls and Enables Doctors to Treat Patients at the Point of Care With More ConfidenceNEW ORLEANS, November 9, 2004 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today introduced SonoCalc IMT software, which allows physicians to effectively measure the intima-media thickness (IMT) of the carotid arteries and assess a patient's risk of cardiovascular disease early. The company made the announcement at the American Heart Association (AHA) Scientific Sessions 2004 in New Orleans, at which there are a number of clinical presentations addressing the benefits of IMT measurement for cardiovascular disease.Twenty years of clinical research has shown that the arterial wall lining or IMT of the carotid arteries becomes thickened years before plaque develops within the vessel. This increased wall thickness is associated with an increased risk of cardiovascular disease, the leading cause of mortality and disability in the United States today.

Worldwide Quarterly Revenue Increases 44% Over Prior YearCompany Reports $0.09 EPSConference Call Today at 1:30 pm PT/4:30 ETBOTHELL, WA - October 28, 2004 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today reported financial results for the quarter ended September 30, 2004. Worldwide revenue in the third quarter of 2004 grew 44% to $29.1 million compared with $20.2 million in the third quarter of 2003. For the first nine months of 2004, the Company's total revenue grew 37% to $78.7 million compared with $57.5 million for the same period of the prior year. Year-over-year, changes in foreign currency rates increased the revenue growth rate by two percentage points for the third quarter and three percentage points for the first nine months of this year. Sonosite reported net income of $1.4 million, or $0.09 per diluted share, for the third quarter of 2004, compared with a net loss of $161,000, or $0.01 per share, in the third quarter of 2003. Year-to-date, Sonosite reported a net loss of $49,000, or breakeven on a per share basis, compared with a net loss of $4.0 million, or $0.28 per share, for the first nine months of 2003.

BOTHELL, WA - October 27, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high performance, hand-carried ultrasound, today announced that it will present at the RBC Dain Rauscher Client Conference at the Seattle Sheraton on Thursday, November 4, 2004 at 08:35 am (PST). The presentation will include a review of the company's business strategy and historical financial results.A live audio-only webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast will find a link to the webcast registration page on Sonosite's website at http://ir.sonosite.com/ . An archived replay of the presentation will also be available approximately one hour following the live presentation and will be available for 30 days. About SonositeSonosite, Inc. ( www.sonosite.com ) is the innovator and world leader in hand-carried ultrasound, with an installed base of more than 20,000 systems. The Company, headquartered near Seattle, Washington is represented by eight subsidiaries and a global distribution netwok in over 75 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The Company employs approximately 450 people worldwide.

Conference Call Accessible Via Live WebcastBOTHELL, WA - October 18, 2004 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today announced that the Company will report its third quarter financial results on Thursday, October 28, 2004 at the close of market and hold a conference call at 1:30 pm PDT/4:30 pm EDT to discuss its third quarter performance, outlook for the rest of 2004 and current corporate developments. The call will be broadcast live and can be accessed via the "Investors" Section of Sonosite's website at www.sonosite.com . A replay of the audio webcast will be available beginning October 28, 2004, 4:30 pm (PDT) until November 12, 2004, 12:00 midnight (PDT) by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code of 981261 is required to access the replay. The call will be also archived on Sonosite's website at http://ir.sonosite.com . About Sonosite

US and Canada's Space Agencies Testing Medical Technology in Undersea Mission Harsh Conditions Simulate SpaceBOTHELL, WA and TORONTO - October 14, 2004 - Sonosite, (Nasdaq:SONO) the world's leader in hand-carried ultrasound, said today that TITAN, the company's compact, high performance system, will take part in a 10-day underwater experiment with NASA Extreme Environment Mission Operations (NEEMO) 7 Mission. Aquanauts will use the laptop-sized ultrasound system to scan each other in simulated emergency situations and transmit live images to St. Joseph's Healthcare in Hamilton, Ontario for review by radiologists. The NEEMO 7 mission to be conducted October 11-21, 2004 is a joint project involving the National Aeronautics and Space Administration (NASA), the Canadian Space Agency (CSA) and the Centre for Minimal Access Surgery (CMAS) at McMaster University of Hamilton, Ontario. The mission aims to demonstrate and evaluate a variety of medical diagnostic and therapeutic technologies to enhance the delivery of state-of-the-art medical care in remote and harsh environments. The experiments will take place off the coast of Key Largo, Fla, 19 meters below the surface of the sea in an underwater habitat called Aquarius. The extreme hostile environment is analogous to human space flight and has been used by NASA in the training of space station astronauts since 2001.